Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

B & F Brüggemann

- PMLiVE

Celgene’s psoriasis pill gives ‘no added benefit’ to patients

Germany’s cost assessor IQWiG says Otezla is not value for money

german flag

German pharma market to edge up to $65bn by 2020

Report finds that laws designed to curb drug prices will also slow down growth

- PMLiVE

Dendreon wins IQWiG U-turn for its immunotherapy Provenge

New data for its troubled cancer drug convinces German HTA body of its added benefit

- PMLiVE

German drug cost containment system ‘aids data transparency’

New study by IQWiG suggests similar rules should be rolled out across Europe

- PMLiVE

Extension for head of Germany’s VFA

Birgit Fischer to remain as chief executive of pharma trade body until 2019          

- PMLiVE

Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

- PMLiVE

Boehringer cuts up to 600 jobs in Germany

Says cutbacks are due to strict drug reimbursement in home nation

- PMLiVE

Germany’s IQWiG denies Astellas’ incontinence drug

But Janssen receives recommendation for hepatitis C treatment Olysio

- PMLiVE

Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

German cost-effectiveness body once again says Fycompa should not be reimbursed

- PMLiVE

AstraZeneca launches diabetes portal in Germany

Zuckerkrank.de is designed to educate patients and families

- PMLiVE

Boehringer planning job cuts in Germany

German newspapers reveals pharma company plans to reduce costs to be able to invest

german flag

Germany to set up eHealth council to promote healthcare technology

Plans new eHealth legislation in the Autumn

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links